iPremom News

Latest iPremom news, funding rounds and robotics & AI coverage. $16M raised. 1 article tracked by The Robotics Media.

About iPremom

Valencia-based iPremom builds a first-trimester blood test that analyzes cell-free RNA in maternal blood to identify risks of pregnancy complications including preeclampsia, preterm birth, fetal-growth restriction and gestational diabetes before clinical symptoms appear.

Key facts

• Headquarters: Valencia, Spain
• Country: Spain
• Founded: 2021
• Sectors: Medical Imaging, Digital Health
• Website: https://ipremom.com

Products by iPremom

• MaiRa Platform (Software, 2026) — iPremom's cell-free RNA analysis platform that estimates the risk of preeclampsia, preterm birth, fetal-growth restriction and gestational diabetes from a singl...

Funding rounds

• Seed — $16M — 2026 — led by Amadeus Capital Partners

Latest iPremom news

• Spain's iPremom Raises €15M Seed To Catch Pregnancy Complications In The First Trimester — Amadeus Capital-led seed pushes iPremom's MaiRa cfRNA platform toward clinical validation for preeclampsia, preterm-birth and gestational-diabetes ris...